Articles
| Open Access |
DOI: INFECTIOUS ENDOCARDITIS, ITS CHALLENGES AND UPDATING THE DUKE CRITERIA: A LITERATURE REVIEW
Bianca Gabriella De Oliveira , Acadêmica de Medicina pela Universidade Salvador-UNIFACS, Salvador-BA, Brazil Melissa Alves Aires Marques , Acadêmica de Medicina pela Universidade Iguaçu-UNIG, Itaperuna-RJ, Brazil Débora Maria Queiroz Brandão , Acadêmica de Medicina pela Universidade Salvador-UNIFACS, Salvador-BA, Brazil Débora Oliveira Moraes , Acadêmica de Medicina pela Universidade Salvador-UNIFACS, Salvador-BA, Brazil Alane Cássia Oliveira Cradoso , cadêmica de Medicina pela Faculdade ZARNS, Salvador-BA, Brazil Luana Vine Passos Lima , Acadêmica de Medicina pela Faculdade ZARNS, Salvador-BA, BrazilAbstract
Infective endocarditis (IE) is an inflammatory process that occurs in the endocardium and also in implantable cardiac devices, the septum between the heart chambers, and in particular the heart valves, whether biological or prosthetic, this process comes from infection by some microorganism, especially bacteria. In 2023, the International Society of Cardiovascular Infectious Diseases (ISCVID) reformulated the diagnostic criteria, in particular those related to microbiological aspects. The aim of this study is to discuss the modified Duke criteria, therapeutic measures, and future challenges. The present study is a narrative bibliographical review that analyzed scientific production in online databases. Because it is a rare pathology, its annual incidence is between 3 and 10 cases per 100,000 people, and it is twice as common in males. Its treatment is complex, but its mainstay is antibiotic therapy and, when necessary, cardiac surgery. Empirical antibiotic treatment should be carried out as soon as possible after blood culture tests have been taken. In conclusion, IE is one of the most laborious and difficult medical conditions for physicians to practice, so it is important to employ a systemic approach based on scientific evidence for diagnostic investigation and therapeutic care for good results and patient well-being.
Keywords
Infective endocarditis, treatment, modified Duke criteria
References
ALMEIDA GMF, et al. O que há de novo no tratamento da endocardite infecciosa: uma revisão integrativa. Brazilian Journal of Health Review, 2023; 6(1): 2119-2132.
ARAÚJO KRS, et al. Ocorrência da endocardite infecciosa em usuários de drogas endovenosas. Research, Society and Development, 2021; 10(3): e170101321108.
BIGNOTO, Tiago (Ed.). Endocardite Infecciosa: Novos Espectros, a Mesma Gravidade. Arquivos Brasileiros de Cardiologia, v. 120, n. 3, p. e20230117, 2023.
CIMMINO G, et al. Current Views on Infective Endocarditis: Changing Epidemiology, Improving Diagnostic Tools and Centering the Patient for Up-to-Date Management. Life 2023; 13(377): 1-18.
CHEN, Edwin et al. Epidemiology and pathophysiology of infective endocarditis. In: Infective Endocarditis. Academic Press, 2022. p. 1-23.
CHIRILLO F. New approach to managing infective endocarditis. Trends in Cardiovascular Medicine, 2020; 15(49): 1-10.
DARGAINS, Renato Rachman. Endocardite infecciosa: revisão de literatura. 2023.
DO CARMO CARVALHO, Lanna et al. Endocardite infecciosa: uma abordagem sobre a variância microbiológica diante diferentes fatores Infectious endocarditis: na approach on microbiological variance in the face of differente factors. Brazilian Journal of Health Review, v. 5, n. 1, p. 2867-2874, 2022.
EL-DALATI, Sami et al. Clinical practice update on infectious endocarditis. The American Journal of Medicine, v. 133, n. 1, p. 44-49, 2020.
FOWLER VG, et al. The 2023 Duke-ISCVID Criteria for Infective Endocarditis: Updating the Modified Duke Criteria. Clinical Infectious Diseases, 2023; 77(4): 518-526.
FYE, W. B. Jean François Fernel. Clinical Cardiology, v. 20, n. 12, p. 1037-1038, 1997
HU, Wangling; WANG, Xindi; SU, Guanhua. Infective endocarditis complicated by embolic events: Pathogenesis and predictors. Clinical cardiology, v. 44, n. 3, p. 307-315, 2021.
KAMDE, Saakshi P.; ANJANKAR, Anil. Pathogenesis, Diagnosis, Antimicrobial Therapy, and Management of Infective Endocarditis, and Its Complications. Cureus, v. 14, n. 9, 2022.
KHALEDI, Mansoor et al. Infective endocarditis by HACEK: a review. Journal of Cardiothoracic Surgery, v. 17, n. 1, p. 185, 2022.
LINDBERG H, et al. Consequences of excluding Enterococcus faecium as a typical endocarditis pathogen in the Duke-ISCVID criteria- endocarditis is endocarditis even if the bacterium is uncommon. Clinical Infectious Diaseases, 2023.
MESQUITA, Claudio Tinoco et al. Endocardite infecciosa: uma revisão narrativa. Medicina, Ciência e Arte, v. 2, n. 1, p. 73-84, 2023.
MCDONALD EG, et al. Guidelines for Diagnosis and Management of Infective Endocarditis in Adults: A WikiGuidelines Group Consensus Statement. JAMA Network Open, 2023; 6(7): e2326366.
REZAR R, et al. Infective endocarditis e A review of current therapy and future challenges. Hellenic Journal of Cardiology, 2021; 62(3): 190-200.
SANTOS, JÉSSICA MOREIRA et al. DESAFIOS DA ENDOCARDITE INFECCIOSA: UMA REVISÃO INTEGRATIVA. Brazilian Journal of Surgery & Clinical Research, v. 32, n. 3, 2020.
SILVA, Nicolas Alvarenga et al. Endocardite infecciosa e atualizações nos Critérios de Duke. Revista Eletrônica Acervo Médico, v. 23, n. 11, p. e14631-e14631, 2023.
SOUSA, Catarina; PINTO, Fausto J. Endocardite Infecciosa: Ainda mais Desafios que Certezas. Arquivos Brasileiros de Cardiologia, v. 118, p. 976-988, 2022.
SUNNERHAGEN, Torgny; SENNEBY, Erik; RASMUSSEN, Magnus. Microorganisms That Commonly Cause Infective Endocarditis: What About Aerococcus in the Duke–International Society for Cardiovascular Infectious Diseases Criteria?. Clinical Infectious Diseases, v. 77, n. 8, p. 1217-1219, 2023.
WILLIAMS, Michael L. et al. Epidemiology of infective endocarditis before versus after change of international guidelines: a systematic review. Therapeutic Advances in Cardiovascular Disease, v. 15, p. 17539447211002687, 2021.
YALLOWITZ AW e DECKER LC. Infectious Endocarditis. StatPearls Treasure Island (FL): StatPearls, 2023.
Article Statistics
Downloads
Copyright License
Copyright (c) 2024 Bianca Gabriella De Oliveira, Melissa Alves Aires Marques, Débora Maria Queiroz Brandão, Débora Oliveira Moraes, Alane Cássia Oliveira Cradoso, Luana Vine Passos Lima
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.